Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage...
34 insider purchases on record · latest filing 2015-05-21.
Insiders have also filed 296 sale transactions at PBYI.